Seeking Alpha

Covidien (COV -7.5%) has completed the separation of its pharmaceuticals business, called...

Covidien (COV -7.5%) has completed the separation of its pharmaceuticals business, called Mallinckrodt, which will begin regular trading on the NYSE today under the symbol MNK. Mallinckrodt issued one share for every eight Covidien shares held on June 19. Covidien is left with its medical devices and supplies operations. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs